Valuation: Clover Corporation Limited

Market Cap 130M 89.63M 78.72M 73.02M 67.09M 127M 8.57B 870M 341M 4.21B 337M 329M 14.56B P/E 2024
54x
P/E 2025 13.2x
Enterprise Value 123M 85.3M 74.92M 69.49M 63.84M 121M 8.16B 828M 324M 4.01B 320M 313M 13.86B EV / Sales 2024
1.29x
EV / Sales 2025 1x
Free-Float
81.18%
Yield 2024
1.53%
Yield 2025 3.15%
1 day+3.31%
1 week+4.70%
Current month-7.69%
1 month-8.77%
3 months-22.00%
6 months-1.27%
Current year-1.27%
1 week 0.7
Extreme 0.705
0.78
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.22
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Director/Board Member - 10/11/2014
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Date Insider Type Main position Quantity % Market Cap.
11-17Sell

Chief Executive Officer

255,199 0.1528%
11-17Buy

Chief Executive Officer

529,638 0.3171%
11-05Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%+4.70%+50.00%-36.07% 87.21M
-1.99%-6.23%+28.92%+77.59% 13B
-2.97%+2.29%-26.11%+245.29% 7.95B
-0.75%-1.18%-20.28%-55.53% 2.3B
+2.15%-2.40% - - 1.46B
+2.16%-8.01%-77.99%-64.06% 1.45B
-0.38%-0.08%+28.68%-0.30% 1.36B
+1.83%-1.48%-29.63%-25.77% 1.23B
+0.19%-0.31%+20.51%+50.58% 1.23B
+4.23%-3.06%-59.53%-63.43% 1.13B
Average +0.78%-0.57%-9.49%+14.25% 3.12B
Weighted average by Cap. -1.21%+0.06%-0.90%+90.55%

Financials

2024 2025
Net sales 62.21M 43.04M 37.8M 35.07M 32.22M 60.91M 4.12B 418M 164M 2.02B 162M 158M 6.99B 86M 59.51M 52.26M 48.48M 44.54M 84.21M 5.69B 578M 226M 2.8B 223M 219M 9.67B
Net income 1.52M 1.05M 921K 854K 785K 1.48M 100M 10.18M 3.99M 49.24M 3.94M 3.85M 170M 7.02M 4.85M 4.26M 3.95M 3.63M 6.87M 464M 47.13M 18.46M 228M 18.22M 17.82M 788M
Net Debt -1.87M -1.3M -1.14M -1.06M -970K -1.83M -124M -12.58M -4.93M -60.84M -4.86M -4.76M -210M -6.26M -4.33M -3.8M -3.53M -3.24M -6.13M -414M -42.06M -16.48M -203M -16.26M -15.91M -704M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
13/07/26 A$0.7800 +3.31% 34,306
10/07/26 A$0.7550 -0.66% 12,038
09/07/26 A$0.7600 -0.65% 2,677
08/07/26 A$0.7650 +1.32% 439,128
07/07/26 A$0.7550 -1.31% 9,913
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Annual profits - Rate of surprise